{"id":"W4387449548","doi":"10.1093/oncolo/oyad254","title":"Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy and Docetaxel in Black Patients From the Randomized ARASENS Trial","year":2023,"lang":"en","type":"article","venue":"The Oncologist","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Institute on Minority Health and Health Disparities; Astellas Pharma; Foundation Medicine; Bayer HealthCare; Pfizer; American Association for Cancer Research; Invitae; Eli Lilly and Company; Lantheus Medical Imaging","keywords":"Docetaxel; Medicine; Placebo; Internal medicine; Clinical endpoint; Androgen deprivation therapy; Prostate cancer; Population; Adverse effect; Enzalutamide; Oncology; Randomized controlled trial; Chemotherapy; Cancer; Androgen receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000929051,0.00007597755,0.0003082276,0.00005862684,0.00004838732,0.00001047893,0.00005024754,0.00004391218,0.00000584384],"category_scores_gemma":[0.0002691254,0.00003241173,0.00002009604,0.0002680476,0.0005130364,0.0000306018,0.0000308287,0.0001210485,0.000001399455],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006237096,"about_ca_system_score_gemma":0.00006184814,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005157358,"about_ca_topic_score_gemma":0.0002004706,"domain_scores_codex":[0.9990631,0.0003018877,0.0002166689,0.0001314904,0.0001718138,0.0001150106],"domain_scores_gemma":[0.9983727,0.00134935,0.00008876482,0.0001309953,0.00003733889,0.00002086511],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8384291,0.0004323102,0.1463791,0.000009656338,0.00008656542,0.000009570141,0.002428123,0.00002311635,0.0002036554,0.0001049227,0.00006578452,0.01182805],"study_design_scores_gemma":[0.5242274,0.0006734331,0.4738322,0.00004144568,0.00002184218,2.978674e-7,0.0001905717,0.0003667933,0.000176967,0.0003993845,0.00004289627,0.00002679768],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929966,0.0002866703,0.000003280504,0.00368239,0.00002740377,0.002801506,0.00001259491,0.00001163735,0.0001779307],"genre_scores_gemma":[0.9964083,0.003269671,0.00001536354,0.00006600227,0.00002200988,0.00007170614,0.00008955558,0.000006241177,0.00005115186],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.327453,"threshold_uncertainty_score":0.1890304,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04382962024491794,"score_gpt":0.3280183482990482,"score_spread":0.2841887280541303,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}